# Proof-Of-Concept Investigation With a Neurosteroid Analog (Ganaxolone) as a Smoking Cessation Candidate

> **NCT01857531** · PHASE2 · COMPLETED · sponsor: **Jed E. Rose** · enrollment: 36 (actual)

## Conditions studied

- Smoking Cessation

## Interventions

- **DRUG:** Ganaxolone
- **DRUG:** Nicotine Patch

## Key facts

- **NCT ID:** NCT01857531
- **Lead sponsor:** Jed E. Rose
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2013-07
- **Final completion:** 2014-02
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2014-09-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01857531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01857531, "Proof-Of-Concept Investigation With a Neurosteroid Analog (Ganaxolone) as a Smoking Cessation Candidate". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01857531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*